Bumper Offer - Urjas oil Just @ Rs. 1
Ibicox Sp is a commercial drug that is prescribed in the form of Tablet. Secondary and off-label uses of Ibicox Sp have also been mentioned below.
The optimal dosage of Ibicox Sp is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. This information has been provided in detail in the dosage section.
The side effects typically associated with Ibicox Sp include Nausea or vomiting, Diarrhoea, Dizziness. Usually, these side effects of Ibicox Sp go away soon, and do not persist beyond the duration of the treatment. However, if these continue for a longer time, consult your doctor right away.
Ibicox Sp's effect during pregnancy is Severe and Severe while nursing. Further, the section on Ibicox Sp related warnings talks about Ibicox Sp's effects on the liver, heart and kidney.
Individuals suffering from medical conditions like Kidney Disease, Asthma, Heart Attack must refrain from the use of Ibicox Sp since this can cause severe adverse effects.
Drug interactions for Ibicox Sp have been reported in the medical literature. Refer to the list below for further details.
In addition to the above precautions for Ibicox Sp, it is important to know that it is not safe while driving, and is not habit-forming.
Ibicox Sp is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| 13 - 18 years (Adolescent) |
|
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Ibicox Sp is used -
Common
Is the use of Ibicox Sp safe for pregnant women?
Pregnant women may get severe side effects after taking Ibicox SP. If you are pregnant, do not take Ibicox SP without a doctor's advice.
Is the use of Ibicox Sp safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Ibicox SP. So it is adviced to consult the doctor before using it.
What is the effect of Ibicox Sp on the Kidneys?
Kidney can be affected by Ibicox SP. If you experience any unwanted effects of this drug, stop taking it. You should take it again only after medical advice.
What is the effect of Ibicox Sp on the Liver?
The liver can be affected by Ibicox SP. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Ibicox SP only after medical advice.
What is the effect of Ibicox Sp on the Heart?
Ibicox SP can have moderate side effects on the heart. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
Ibicox Sp should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
If you are suffering from any of the following diseases, you should not take Ibicox Sp unless your doctor advises you to do so -
Is this Ibicox Sp habit forming or addictive?
No, there is no any evidence that Ibicox Sp is addictive.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Ibicox Sp. So it is best to avoid driving.
Is it safe?
Yes, Ibicox Sp is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
No, Ibicox Sp is not used to treat mental disorders.
Interaction between Food and Ibicox Sp
There is no information on the effects of taking Ibicox Sp with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Ibicox Sp
It is difficult to say anything about the effect of Ibicox Sp and alcohol. No research has been done on this yet.
No, Ibicox SP cannot be taken with ibuprofen. It may increase the chances of side effects if taken together. However, if you experience any undesirable effects after consuming medicine, please inform the doctor and follow his/her instructions.
Rarely Ibicox SP causes drowsiness. However, if you experience drowsiness after taking this medicine do not indulge in activities which include driving, operating heavy machinery. You are advised to take rest and if need be ask your doctor for some other drug options.
Ibicox SP is a pain relieving medicine. One should take as long as he/she has been recommended to take. However, sometimes even after symptomatic relief your doctor may ask you to continue with medication to reduce inflammations in the body.
Ibicox SP is a brand name for aceclofenac. It is a prescription drug that belongs to the class of medications called NSAIDs (Nonsteroidal anti-inflammatory drug). It is mainly used to relieve pain in a patient's suffering from rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis. Additionally, it also reduces fever.
Ibicox SP is a prescription drug so do not take it without consulting a doctor. It can be harmful for patient's to take this drug unnessacarily without doctor's advise.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
KD Tripathi. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
KD Tripathi. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 206-207
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Acetaminophen (acetaminophen)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ofirmev (acetaminophen)
Package Leaflet Information For The User [Internet]: Aceclofenac 100 mg film-coated Tablets. Accord Healthcare Limited
Package leaflet Information for the patient [Internet]: Paracetamol Tablets 500mg. actavis
Shivani Bhagat*, Monika Agarwal, Vandana Roy [Internet]: Serratiopeptidase: A systematic review of the existing evidence. International Journal of Surgery 11 (2013) 209e217
